This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Byth, K. Articles by Gebski, V. Search for Related Content PubMed PubMed Citation Articles by Byth, K. Articles by Gebski, V. Social Bookmarking                         What's this?

Factorial designs: a graphical aid for choosing study designs accounting for interaction

NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown NSW 1450, Australia; kbyth{at}ctc.usyd.edu.au

Val Gebski

NHMRC Clinical Trials Centre, University of Sydney, Camperdown NSW 1450, Australia

The presence of possible treatment interaction when designing a factorial study can be either greeted with dismay (for an antagonistic or negative interaction) or can be welcome (in the case of a synergistic effect). The type of potential interaction may greatly influence the choice of study design. Depending on the magnitude of an expected additive or multiplicative interaction, a three-arm study, instead of a 2 x 2 factorial, may yield greater statistical power. A graphical aid for examining the loss of power due to the presence of such interaction is developed. The technique can also be applied to designing studies where prespecified subgroup analyses are of particular interest. Tests for interaction effects between subgroups are usually underpowered, even if the subgroups have been prespecified in the protocol. The technique can be used to determine the appropriate sample sizes in the subgroups to ensure adequate power to detect potential interaction effects. The method is illustrated with respect to a published 2 x 2 factorial study. In this study, interaction reduced the power of the final analysis to detect significant main effects.

Clinical Trials, Vol. 1, No. 3, 315-325 (2004)
DOI: 10.1191/1740774504cn026oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?